skip to Main Content
TES Pharma | Drug Discovery Innovation

First α-Amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD) Patent Published

TES Pharma announces the granting of the first ACMSD patent, US9,708,272(B2), in its ACMSD patent portfolio. The patent discloses the first know drug-like inhibitors of ACMSD. Compounds from our ACMSD project are currently being progressed towards candidate selection.

Back To Top